mckinleymedia, Author at Personalis

About mckinleymedia

This author has not yet filled in any details.
So far mckinleymedia has created 218 blog entries.

2 Aug, 2021

Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance Mechanisms

Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance Mechanisms Clinical Cancer Research August 2021 Volume 27, Issue 15 This work evaluates the predictive strength of a composite biomarker, neoantigen presentation score (NEOPS), in a cohort of patients with late-stage melanoma. NEOPS incorporates damaging events [...]

24 Jun, 2021

NeXT Level Biomarkers Symposium: Welcome Message

2021 NeXT Level Biomarkers Symposium: Welcome Message Richard Chen, MD, MS Chief Scientific Officer Personalis, Inc.

24 Jun, 2021

NeXT Dx and Companion Diagnostics (CDx) with Personalis

2021 NeXT Level Biomarkers Symposium: NeXT Dx and Companion Diagnostics (CDx) with Personalis Twinkal Marfatia, PhD Sr. Product Manager – Clinical Products Personalis, Inc. Dawn McHugh Sr. Director, Strategic Business Development Personalis, Inc.

24 Jun, 2021

NeXT Liquid Biopsy Overview and Review of AACR Data

2021 NeXT Level Biomarkers Symposium: NeXT Liquid Biopsy Overview and Review of AACR Data Sean Boyle, PhD Senior Director, Bioinformatics Applications Personalis, Inc. Dan Norton, MBA Senior Product Manager Personalis, Inc.

24 Jun, 2021

Parker Institute Case Study: The PRINCE Trial

2021 NeXT Level Biomarkers Symposium: Parker Institute Case Study: The PRINCE Trial Theresa LaVallee, PhD Vice President, Translation Medicine and Regulatory Affairs Parker Institute for Cancer Immunotherapy Lee McDaniel, MD, MSE Sr. Bioinformatics Scientist Personalis, Inc.

24 Jun, 2021

Composite Biomarkers and our Neoantigen Presentation Score (NEOPS)

2021 NeXT Level Biomarkers Symposium: Composite Biomarkers and our Neoantigen Presentation Score (NEOPS) Charles Abbott, PhD Manager, Bioinformatics Science Personalis, Inc.

24 Jun, 2021

SHERPA, Neoantigen Binding Prediction and Biomarker Discovery

2021 NeXT Level Biomarkers Symposium: Neoantigen Binding Prediction and Biomarker Discovery with SHERPA Sean Boyle, PhD Senior Director, Bioinformatics Applications Personalis, Inc.

23 Jun, 2021

Exploring HLA LOH With the DASH (Deletion of Allele-Specific HLAs) Algorithm – Form

2021 NeXT Level Biomarkers Symposium: Exploring HLA LOH With the DASH (Deletion of Allele-Specific HLAs) Algorithm Rachel Pyke, PhD Manager, Bioinformatics Applications Personalis, Inc.

2 Jun, 2021

Pharma Research Solutions

Pharma Research Solutions Comprehensive genomics for drug discovery and preclinical development Genomic Insights for Optimizing Drug DevelopmentWith our Pharma Research Services portfolio of broad-content next-generation sequencing (NGS) assays and analytics, we can comprehensively address the needs of biopharmaceutical companies who wish to integrate high quality and high-accuracy genomic and/or transcriptomic [...]

24 May, 2021

2021 AACR: Longitudinal Exome-Scale Liquid Biopsy Monitoring of Evolving Therapeutic Resistance Mechanisms in Head and Neck Squamous Cell Carcinoma Patients Receiving Anti-PD-1 Therapy

2021 AACR: Longitudinal Exome-Scale Liquid Biopsy Monitoring of Evolving Therapeutic Resistance Mechanisms in Head and Neck Squamous Cell Carcinoma Patients Receiving Anti-PD-1 Therapy Typical liquid biopsy panels capture a relatively small number of variants, and likely under-represent the heterogeneity of resistance in late-stage cancers. To address the challenges associated with identifying multiple concurrent heterogeneous [...]

12 Next